key: cord-0961815-g5pb5r9w
authors: Lyu, Ming; Fan, Guanwei; Xiao, Guangxu; Wang, Taiyi; Xu, Dong; Gao, Jie; Ge, Shaoqin; Li, Qingling; Ma, Yuling; Zhang, Han; Wang, Jigang; Cui, Yuanlu; Zhang, Junhua; Zhu, Yan; Zhang, Boli
title: Traditional Chinese medicine in COVID-19
date: 2021-09-20
journal: Acta Pharm Sin B
DOI: 10.1016/j.apsb.2021.09.008
sha: ed3a5dd07114472f65bd904de6093f8bdba6c974
doc_id: 961815
cord_uid: g5pb5r9w

COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the globe, posing an enormous threat to public health and safety. Traditional Chinese medicine (TCM), in combination with Western medicine (WM), has made important and lasting contributions in the battle against COVID-19. In this review, updated clinical effects and potential mechanisms of TCM, presented in newly recognized three distinct phases of the disease, are summarized and discussed. By integrating the available clinical and preclinical evidence, the efficacies and underlying mechanisms of TCM on COVID-19, including the highly recommended three Chinese patent medicines and three Chinese medicine formulas, are described in a panorama. We hope that this comprehensive review not only provides a reference for health care professionals and the public to recognize the significant contributions of TCM for COVID-19, but also serves as an evidence-based in-depth summary and analysis to facilitate understanding the true scientific value of TCM.

based on Table 1, the clinical evidence of TCM for typical characteristics of COVID-19 were analyzed and summarized in Table 2 For severe or critical stages: 1) Xuebijing injection 213 164 . In addition, a Vero E6 cell-based large-scale anti-SARS-CoV-2 activity of 1058 natural compounds were screened, and 17 newly discovered compounds showed strong anti-virus propagation effects with the IC 50 values ranging from 0.011 to 11.03 µmol/L. Among them, bufalin from toad venom (Chansu) exerted the antiviral effect with an IC 50 of 18 nmol/L by targeting the ion transport function of Na + /K + -ATPase 139 . Theaflavin was predicted to exert anti-viral replication by inhibiting RdRp activity 130 . The binding affinities with the critical proteins of a portion of ingredients presented above were also predicted by in silico screening and molecular docking 124, 168 . Whether these TCM ingredients could be used to combat COVID-19 need further in vitro and in vivo validation. Pharmacokinetic profiles including absorption, distribution, metabolism, and excretion (ADME) on the promising leads should be further studied.

Antiviral monotherapy for patients hospitalized with COVID-19 is quite not enough, especially for severely and critically ill patients 169 . Except for the broad-spectrum antiviral activity, TCM process advantages in regulating immune response, suppressing cytokine storm through multiple avenues [170] [171] [172] . Beyond inhibiting virus replication, Lianhua Qingwen capsule 89 and Liu Shen capsule 107 reduced proinflammatory cytokines production such as TNF-α, IL-6, MCP-1, and IP-10 in SARS-CoV-2 infected Huh-7 cells. In addition, Lianhua Qingwen capsule was analyzed to repair lung injury by modulating inflammatory process and cytokine storm 90 . Maxing J o u r n a l P r e -p r o o f Shigan decoction is the basic prescription of "three medicines and three formulas" apart from Xuebijing injection, was revealed to regulate immunity and reduce cytokine storm, as well as protect alveolar-capillary barrier of lung and relieve pulmonary edema by utilizing integrated network pharmacological approaches 101 . As same as Maxing Shigan decoction, Qingfei Paidu decoction showed multiple immune regulation, anti-inflammation, and lung injury-repair activities with its main ingredients of baicalin, glycyrrhizin, hesperidin, and hyperoside by targeting proteins including TNF-α, IL-6, IL-10, and CCL2 93-96 . Furthermore, several ingredients such as baicalin and glycyrrhizin of Qingfei Paidu decoction could inhibit platelet aggregation 96 . Dayuanyin is the basic formula of Qingfei Dayuan granules that might process an anti-inflammatory and immunoregulatory effects via acting on IL-6, IL-1β, and MCP-1, with its ingredients containing kaempferol, isoflavone, and formononetin 63,104 . Glycyrrhizin is an anti-viral agent and clinically used antiinflammatory ingredient from Glycyrrhiza uralensis (Gancao) was determined to elevate immunity and suppress inflammatory stress through T cell receptor and VEGF signaling pathways 141, 159, 173 . Matrine was not only predicted to suppress host cell apoptosis and inflammation by targeting the TNF-α, IL-6, and CASP3 in the TNF signaling, but also validated to reduce lung tissue damage and lung index by decreasing the production of IL-6, IL-10, TNF-α, and IFN-γ, increasing the percentage of CD4 + T cells, CD8 + T cells, and B cells in peripheral blood, and lessening viral load in lung tissue in a mouse model combining human coronavirus pneumonia with cold-dampness pestilence attacking the lung 112,113 . Although systems pharmacology is a convenient and effective tool to propose the mechanism of action of TCM at a holistic level, all the results above need to be further validated. IL-6 was considered as one of the most important molecules in cytokine storm [174] [175] [176] [177] [178] [179] [180] [181] [182] . Administration with Dayuanyin reduced the level of IL-6 in mild, moderate, and even severe clinical stages of COVID-19 104 . Besides, Shufeng Jiedu capsule 54 , Yidutoxicity blocking lung decoction 62 , Qingfei Touxie Fuzheng recipe 67 , and diammonium glycyrrhizinate 70 were confirmed to decrease the level of IL-6 in COVID-19 patients, as seen in Table 1 . Interestingly, except for the strong anti-SARS-CoV-2 activity 137 , artemisinin and its derivatives regulated multiple immune cells including macrophage, monocyte, dendritic cell, and T cell to inhibit proinflammatory cytokine release and cytokine storm outbreak to protect tissues from injury 183 (Table 3) .

In contrast with WM therapy, TCM is adept at treating complications of COVID-19 such as ARDS and MODS which are likely caused by the concurrence of viral toxicity, endothelial damage, cytokine storm, excessive immune, and microthrombus holistically (Table 3) . Xuebijing injection was certified to treat severe pneumonia, sepsis, coagulopathy, SIRS, and MODS, owing to its various effects on cytokine reduction, immunoregulation, microcirculation improvement, anti-coagulation, proangiogenesis, and neutralization of released bacterial cytotoxins 42,184-189 . Xuebijing injection was able to improve the oxygenation index of PaO 2 /FiO 2 and reduce the level of pro-inflammatory cytokines of TNF-α, IP-10, MIP-1β, and RANTES in the treatment of COVID-19 42,43 . It was also reported that Xuebijing injection could downregulate the expression of IL-6, IL-1, TLR4, MAPK, and NF-κB, maintain the balance of Tregs and Th17 cells in acute lung injury [190] [191] [192] [193] . Besides, Xuebijing injection processed the potential to alleviate liver damage, acute lung injury-induced left ventricular ischemia/reperfusion, sepsis-induced acute kidney injury, and sepsisinduced myocardial injury via inhibiting inflammation, apoptosis, and endothelial injury [194] [195] [196] [197] [198] [199] . Systems pharmacological analysis revealed that Qingfei Paidu decoction could protect multi-organ including nervous system, sensory system, digestive system, and circulatory system by regulating key enzymes, G protein-coupled receptors, ion channels, and transporters 96 .

In the background of great demands for acute lung injury and ARDS therapy of COVID-19, more than one hundred of natural products from TCM with their potential J o u r n a l P r e -p r o o f benefits and underlying mechanisms of anti-inflammation, antioxidant stress, antiapoptosis, and anti-pulmonary fibrosis were summarized and categorized. According to their chemical structures, these were divided into flavonoids (e.g., luteolin, baicalein), alkaloids (e.g., berberine, matrine), terpenoids (e.g., pogostone, andrographolide), polyphenols (e.g., honokiol, curcumin), quinonoids (e.g., emodin, shikonin), and other compounds (e.g., osthole, imperatorin) 200 . In addition, a systematic review and meta-analysis of 19 eligible RCTs including Tanreqing injection, Shengmai injection, Shenfu injection, Danshen injection, Reduning injection, and Xuebijing injection demonstrated that Chinese medicine injections were adjuvant therapy with great potential benefits for the treatment of ALI/ARDS 33 . For example, based on the effects of inhibiting inflammatory cytokines of IL-6, IL-8, IL-1β, and TNF-α, regulating immune, and elevating the oxygenation index of PaO 2 , Tanreqing injection was proved to improve lung injury, pulmonary infection, airway inflammation, and airway mucus hypersecretion [201] [202] [203] [204] . Reduning injection was demonstrated to prevent pulmonary neutrophil infiltration, lung injury and severe pneumonia which may attribute to downregulating IL-1β, IL-18, TNF-α, NF-κB, and pyrin domain containing 3 levels, lowering myeloperoxidase activities, and reducing reactive oxygen species production [205] [206] [207] . Xiyanping injection, a famous Chinese medicinal preparation of andrographolide sulfonate, was reputed as one of the most effective alternatives to antibiotics, which has been widely used to ameliorate lung damage, bronchitis and community acquired pneumonia probably through inhibiting NF-κB and MAPK-mediated inflammatory responses 208, 209 . Besides, Xiyanping injection and Reduning injection were used to treat diarrhea in children. Xiyanping injection could ameliorate colitis by inhibiting Th1/Th17 response in mice 210 .

Cardiovascular disease is a high frequent comorbidity and complication of COVID-19. Three Chinese injection medicines including Shenfu injection, Shengmai injection, and Shenmai injection, have both pulmonary and cardiac protective effects.

For instance, Shenfu injection is effective in the treatment of heart failure, myocardial J o u r n a l P r e -p r o o f hypertrophy, cardiac arrest, myocardial ischemia-reperfusion injury, myocardial fibrosis, and acute viral myocarditis, partly through suppressing apoptosis and inflammation, improving microcirculation, reducing mitochondrial damage and coagulation-fibrinolysis disorders [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] . Moreover, Shenfu injection has a protective effect on gastrointestinal tract and intestinal mucosa 222,223 . Xingnaojing injection and Angong Niuhuang pill are different preparations share similar ingredients for stroke treatment in clinic. Both of them ameliorate cerebral ischemia/reperfusion injury, cerebral infarction, cerebral edema, blood-brain barrier disruption, and acute cerebral hemorrhage because of their benefits in brain microvascular endothelial cells, hippocampal and cortical neurons protection, and their anti-inflammation and antiapoptosis effects 224-231 .

Analyses of the main compositions of the "three medicines and three formulas" and other related literatures identified Glycyrrhiza uralensis (Gancao), Ephedrae Herba Gut microbiome is involved in disease severity and host inflammatory and immune responses in COVID-19 patients 233 . It is worth noting that the anti-COVID-Paidu decoction dose-dependently regulates the host metabolism and gut microbiome in rats, indicating that altering gut microbiota composition may be part of the anti-COVID-19 mechanisms of Qingfei Paidu decoction 237 . It is of particularly significance to consider that the solubility and bioavailability of certain TCM ingredients, such as resveratrol, quercetin, baicalin, curcurmin, emodin, and tanshinone IIA, are limited, leading to poor absorption into the bloodstream after oral administration. These ingredients may exert their therapeutic effects though interplaying with gut microbiota 238 . For instance, resveratrol could also alleviate intestinal inflammation and oxidative damage by modulating the composition of gut microbiota in addition to the direct antiviral effect 239 . What's more, to improve the bioavailability, a nano-micellar form of curcumin was used to decrease IL-6 and IL-1β expression and secretion in patients with COVID-19 240 .

In summary of preclinical evidence, the anti-COVID-19 effects and mechanisms of TCM include but not limited to 1) inhibiting SARS-CoV-2 invasion and replication by targeting the key proteins of spike, ACE2, TMPRSS2, 3CLpro, PLpro, RdRp, and spike-ACE2 interaction; 2) regulating immune and inflammatory response by targeting inflammatory cytokines such as IL-1, TNF-α, and IL-8, and chemokines like CCL5, CCL2, and IP-10, which are secreted by monocytes, macrophages, dendritic cells, CD4 + T cells, and CD8 + T cells; 3) protecting against ARDS and MODS by suppressing the crosstalk of viral toxicity, endothelial damage, cytokine storm, excessive immune, and microthrombus by targeting IL-6, CRP, D-dimer, and procalcitonin.

Finally, by integrating the clinical evidence and potential mechanisms of TCM for COVID-19, a panorama is drawn in Fig. 3 , hoping that the effect and mechanism of TCM for COVID-19 could be viewed and understood within a single framework.

Although a great quantity of review articles have been published on the topic of TCM in COVID-19 13, 14, 19, 23, 25, 35, 71, 87, 168, 171, , our work offers something unique. 1) To our knowledge, this is the first review of TCM on COVID-19 that integrates evidence-based scientific findings from bedside to bench with the most comprehensive and updated literatures. 2) The pathogenesis and penitential mechanisms of TCM remedy in three phases corresponding to distinct stages for COVID-19 are first systematically described and presented within a single panorama by integrating available clinical and fundamental evidence.

A valuable lesson learned from China's COVID-19 battle is that perseverance in combination of TCM and WM is the right and sensible choice 71,249 . Looking ahead, several critical issues need to be addressed as we prepare to face similar or even more serious global health threats in the future. Firstly, as the pandemic continues to evolve, the pathogenesis of COVID-19 is not fully elucidated. It is reasonable to postulate that the crosstalk of viral toxicity, endothelial damage, cytokine storm, excessive immune, and microthrombus are essential contributors for severely or critically ill patients with COVID-19, which need to be validated further. Secondly, due to a lack of in-depth understanding, there are still some skepticisms on the validity of treating COVID-19 with TCM [278] [279] [280] . More RCTs with high accuracy, clinical safety, rigorous design, and large sample, as well as in-depth mechanistic explorations with compatibility principal should be conducted to provide more reliable evidence for TCM in COVID-19 intervention, especially for the highly recommended three CPMs and three Chinese medicine formulas. Thirdly, the rehabilitative effects of TCM ought to be continuous concerned and long-term medical observed for the COVID-19 patients in recovery phase, especially for the aged. A recent paper published in The Lancet on 6-month consequences of 1733 COVID-19 patients revealed that those with severe disease discharged from hospital showed common syndromes of fatigue or muscle weakness, sleep difficulties, and anxiety or depression 281, 282 . Meanwhile, a comparison of 425 non-treatment with 143 TCM-treated COVID-19 patients post discharge showed that TCM was beneficial for decreasing IL-6 and procalcitonin, and increasing red blood cell, hemoglobin, and platelet count 283 . 

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs

Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis

The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis

International expert meeting on the treatment of SARS by traditional Chinese medicine, and the integration of traditional Chinese medicine with Western medicine . SARS: clinical trials on treatment using a combination of traditional Chinese medicine and Western medicine: report of the WHO international expert meeting to review and analyse clinical reports on combination treatment for SARS

Using herbal medicine as a means of prevention experience during the SARS crisis

The lesson of supplementary treatment with Chinese medicine on severe laboratoryconfirmed SARS patients

Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS

Research on medication for severe type of COVID-19 based on Huashi Baidu prescription

Analysis of traditional Chinese medicine diagnosis and treatment strategies for COVID-19 based on "the diagnosis and treatment program for coronavirus disease-2019" from Chinese authority

Discussion on traditional Chinese medicine prevention and treatment strategies of coronavirus disease 2019 (COVID-19) from the perspective of "cold-dampness pestilence

The scientific foundation of Chinese herbal medicine against COVID-19

Reflections on treatment of COVID-19 with traditional Chinese medicine

Treatment of coronavirus disease 2019 (COVID-19) from perspective of dampness-toxicity plagues

Expert consensus on prevention and treatment of COVID-19 by integrating traditional Chinese and Western medicine

Clinical practice

Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: a review

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs

Glycyrrhizin effectively neutralizes SARS-CoV-2 in vitro by inhibiting the viral main protease

Resveratrol and pterostilbene potently inhibit SARS-CoV-2 infection in vitro

KD-1) exerts antiviral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-kappaB) signaling pathway

Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach

Anti-SARS-CoV-2 potential of artemisinins in vitro

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening

Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases

Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

Inhibition of SARS-CoV 3CL protease by flavonoids

Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition

Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus

Papainlike protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits

phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia

Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa

Glycyrrhizin, an active component of liquorice roots, and replication of SARSassociated coronavirus

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

Glycyrrhizin: an alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?

Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro

Small molecules targeting severe acute respiratory syndrome human coronavirus

Identification of natural compounds with antiviral activities against SARS-associated coronavirus

COVID-19: consider cytokine storm syndromes and immunosuppression

Cytokine release syndrome in severe COVID-19

Effective treatment of severe COVID-19 patients with tocilizumab

Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: a prospective cohort study

Coronavirus disease-2019 treatment strategies targeting interleukin-6 signaling and herbal medicine

The role of Interleukin 6 inhibitors in therapy of severe COVID-19

Cytokine storm in COVID-19: the current evidence and treatment strategies

Intravenous infusion of Chinese medicine Xuebijing for patients with severe pneumonia: a multicenter, randomised, double-blind controlled trial

Network pharmacologyguided development of a novel integrative regimen to prevent acute graft-vs.-host disease

Effects of Xuebijing injection on microcirculation in septic shock

Treatment effects of xuebijing injection in severe septic patients with disseminated intravascular coagulation

XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial

Efficacy of Xuebijing for coagulopathy in patients with sepsis

Protective effect of Xuebijing injection on paraquat-induced pulmonary injury via downregulating the expression of p38 MAPK in rats

Xuebijing injection induces anti-inflammatory-like effects and downregulates the expression of TLR4 and NF-kappaB in lung injury caused by dichlorvos poisoning

Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro-and antiinflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis

Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis

Protective effect of Xuebijing injection on myocardial injury in patients with sepsis: a randomized clinical trial

Reduning injection ameliorates paraquat-induced acute lung injury by regulating AMPK/MAPK/NF-kappaB signaling

Reduning plus ribavirin display synergistic activity against severe pneumonia induced by H1N1 influenza A virus in mice

Anti-inflammatory effects of Reduning Injection on lipopolysaccharide-induced acute lung injury of rats

Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-kappaB pathways

Cost-effectiveness analysis of Xiyanping injection (andrographolide sulfonate) for treatment of adult community acquired pneumonia: a retrospective, propensity score-matched cohort study

Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response

Effects of Shen-Fu injection on coagulation-fibrinolysis disorders in a porcine model of cardiac arrest

Shenfu Formula reduces cardiomyocyte apoptosis in heart failure rats by regulating microRNAs

Shenfu Injection attenuates rat myocardial hypertrophy by up-regulating miR-19a-3p expression

Efficacy and safety of combination therapy of Shenfu injection and postresuscitation bundle in patients with return of spontaneous circulation after in-hospital cardiac arrest: a randomized, assessor-blinded, controlled trial

Shenfu Injection inhibits inflammation in patients with acute myocardial infarction complicated by cardiac shock

Protective effects of Shenfu injection against myocardial ischemia-reperfusion injury via activation of eNOS in rats

Effects of Shenfu injection on survival and neurological outcome after out-of-hospital cardiac arrest: a randomised controlled trial

Effects of Shenfu injection on macrocirculation and microcirculation during cardiopulmonary resuscitation

Cardioprotection against heart failure by Shenfu Injection via TGF-beta/Smads signaling pathway

Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients

Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19

Chinese herbal medicine: fighting SARS-CoV-2 infection on all fronts

Traditional Chinese herbal medicine at the forefront battle against COVID-19: clinical experience and scientific basis

The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19

Current prevention of COVID-19: natural products and herbal medicine

A pharmacology-based comprehensive review on medicinal plants and phytoactive constituents possibly effective in the management of COVID-19

Chinese medicine against coronavirus disease 2019 (COVID-19)

The role of Chinese medicine in COVID-19 pneumonia: a systematic review and meta-analysis

Current status of potential therapeutic candidates for the COVID-19 crisis

Traditional Chinese medicine contributes to the treatment of COVID-19 patients

Chinese medicine in fighting against Covid-19: role and inspiration

The potential insights of traditional Chinese medicine on treatment of COVID-19

Traditional Chinese medicine treatment of COVID-19

Chinese patent medicines in the treatment of coronavirus disease 2019 (COVID-19) in China

Current state of research about Chinese herbal medicines (CHM) for the treatment of coronavirus disease 2019 (COVID-19): a scoping review

The effects of traditional Chinese medicine as an auxiliary treatment for COVID-19: a systematic review and meta-analysis

Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)

Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review

Candidate drugs against SARS-CoV-2 and COVID-19

Traditional Chinese medicine for COVID-19 treatment

Contribution of traditional Chinese medicine to the treatment of COVID-19

Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism

Prevention and treatment of COVID-19 using traditional Chinese medicine: a review

Potential mechanisms of Chinese herbal medicine that implicated in the treatment of COVID-19 related renal injury

Traditional Chinese medicine for treatment of coronavirus disease 2019: a review

Natural product-derived phytochemicals as potential agents against coronaviruses: a review

The use of Traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good

Use of herbal drugs to treat COVID-19 should be with caution

Reply to "The use of traditional Chinese

medicines to treat SARS-CoV-2 may cause more harm than good

6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study

Long-term consequences of COVID-19: research needs

Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19

This study was supported by grants from National Science and Technology